Development of Biomarkers for Monitoring Menopause in Women
Eligible age
20+ yrs
Accepts
Women
Locations
0 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This cross-sectional study aims to develop and validate mitochondrial biomarkers for monitoring menopause in women. The study will involve 100 participants divided into three groups: reproductive period, perimenopausal transition period, and postmenopausal period. Peripheral blood samples will be collected, and mitochondrial quality and quantity will be assessed using both qualitative and quantitative analyses. The study will identify potential biomarkers through metabolomics and validate them for monitoring the perimenopausal transition, providing a novel approach for women's health management during menopause.
Sponsor: Fu Jen Catholic University Hospital
You may qualify if…
- ✓ Biological female, age order than 20 years old.
You may not qualify if…
- ✕ Person with cancer.
- ✕ Person with any known acute or chronic infection.
- ✕ Person with known chronic illness under follow up or treatment.
- ✕ Pregnancy, one year withing delivery, under breast feeding, or three months within breast feeding.
- ✕ Under any female horemone therapy.
Source: ClinicalTrials.gov · NCT06852755 · last updated 2025-05-25